|
Prev 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 Next
|
|
| |
|
Mar '04
|
|
Montreal Cops Uniquely Anti-Positive
| |
Montreal has adopted hiring standards for its police force, stipulating that HIV-positive candidates will not be hired. A survey of other professions and trades whose members have
close contact with the public revealed that they have no such rule. |
|
|
Feb '04
|
|
Tax Cuts for the Ultra-Rich, While Poor PWAs Die Waiting for Meds
| |
At a time when the Bush administration has cut taxes for the country's multi-millionaires, some US patients are being denied access to anti-retroviral treatment. |
|
|
Feb '04
|
|
Throwing Used Scumbags at Prison Guards?
| |
A proposal to put condom-vending machines in Tasmanian prisons is expected to be approved early this year. |
|
|
Feb '04
|
|
PET Scans Detect HIV Progression
| |
Positron emission tomography (PET) scans can track the progression of HIV and could lead to new treatment options and the development of the next generation of AIDS drugs, according to two recent studies. PET scans, usually used to identify cancerous tumors, could help
fight AIDS by identifying the virus' impact on lymph nodes, which could be treated with radiotherapy or surgery. |
|
|
Feb '04
|
|
Safe Site Popular with Junkies
| |
The roughly 5,000 heroin addicts in Vancouver's Downtown Eastside neighborhood prefer the city's first legal supervised safe injection site to drug use on the street, but some fear one such site is not enough. |
|
|
Feb '04
|
|
Mouth's Defenses Against HIV
| |
Researchers at Case Western Reserve University and the Cleveland Clinic have discovered a way the mouth may prevent contracting HIV. |
|
|
Feb '04
|
|
Norvir Price Soars
| |
Last month, the price of widely used protease inhibitor Norvir leapt by 500 percent, to $8.50 per day for 100 milligrams, confirmed Abbott spokesperson Laureen Cassidy. |
|
|
Jan '04
|
|
Un-Used Meds for Africa
| |
The Starfish Project is an international HIV/AIDS treatment initiative, which provides both technical support and material resources to health care providers and community workers in limited-resource settings. The Project is a program of the Center for Special Studies (CSS),
an independent AIDS clinic located at Weill Cornell/New York Presbyterian Medical Center, in New York City, New York.Current operations are focused in Southwest Nigeria. |
|
|
Dec '03
|
|
Peptide T Holds Promise
| |
An elusive goal of HIV/AIDS researchers has long been to find a way to flush the virus out of latently infected cells so that it can be attacked by antiviral regimens. |
|
|
Dec '03
|
|
PCP in the HAART Era
| |
Since the advent of highly active antiretroviral therapy (HAART), reported incidence of opportunistic infections (OI) in HIV patients has markedly decreased. |
|
|
Dec '03
|
|
Six Months After HAART: Optimum Prognosis Time?
| |
A recent study suggests that six months after beginning HAART may be the optimum time for determining a patient's prognosis, rather than before the start of treatment. |
|
|
Nov '03
|
|
Kaletra's Five Year Check Up
| |
In a five-year study, most patients using Abbott Laboratories' HIV drug Kaletra achieved and maintained undetectable viral levels and did not develop drug resistance. |
|
|
Nov '03
|
|
Tiny Protein Could Be Key to AIDS Puzzle
| |
Virion infectivity factor, or Vif, is a component of HIV that neutralizes APOBEC3G, a powerful human cell enzyme that can sabotage the genetic machinery of viruses similar to HIV. |
|
|
Nov '03
|
|
Emtriva Receives FDA Nod
| |
The Food and Drug Administration based its summer approval of Emtriva for use in combination with other antiretroviral agents on data from two 48-week clinical trials. |
|
|
Nov '03
|
|
Vaccines Still Elusive, But Trials Now Include Humans
| |
Despite recent discouraging news, there was reason for optimism at the recent AIDS Vaccine conference in New York. |
|
|
Nov '03
|
|
AIDS Group Wants Trizivir Off Market
| |
The nation's largest AIDS organization has asked federal regulators to withdraw approval for GlaxoSmithKline's drug Trizivir in light of a study showing it was inferior to other treatment combinations. |
|
|
Nov '03
|
|
Life Expectancy Tumbles to 33 Years
| |
The life expectancy of Zimbabweans has dropped to about 33 years from 67.5 years, concurrent with the HIV/AIDS epidemic, according to the UN Development Program's 2003 humanitarian report. |
|
|
Nov '03
|
|
Ritonavir-Boosted Reyataz: Fewer Lipid Problems?
| |
Data presented at the 2nd International AIDS Society Conference on HIV Pathogenesis and Treatment, held in Paris, demonstrated that a treatment regimen combining the new drug Reyataz, boosted with low-dose
ritonavir, provided antiviral effect comparable to a standard-of- care protease inhibitor regimen containing the ritonavir-boosted PI lopinavir (Kaletra) in highly treatment-experienced HIV patients after 24 weeks of treatment. |
|
|
Oct '03
|
|
More Promise for Fuzeon
| |
The HIV drug Fuzeon showed encouraging results when used over a longer term than previously studied, and could be made available for more patients than previously anticipated, according to its maker, Roche. |
|
|
Oct '03
|
|
Gonorrhea Making Comeback
| |
Gonorrhea is on the rise in Canada and growing dangerously resistant to even the most potent antibiotics. |
|
|
Oct '03
|
|
Life Expectancy Falls to 33 Years
| |
from the Financial Gazette (Harare) |
|
|
Oct '03
|
|
Anti-HIV Drugs Save Vision
| |
In two separate studies, Johns Hopkins University researchers recently reported that highly active antiretroviral therapy saves the eyesight as well as the lives of HIV patients, and that among AIDS patients with longstanding vision problems, those who took HAART reported
higher overall quality of life. |
|
|
Oct '03
|
|
Blood Test May Predict Dementia
| |
Certain protein patterns in blood cells may indicate that an HIV patient is at risk of dementia, according to a study released last month. |
|
|
Sep '03
|
|
US Approves New Once-a-Day AIDS Drug
| |
Gilead Sciences received approval from the US Food and Drug Administration last month for a new once-a-day AIDS drug, Emtriva. |
|
|
Sep '03
|
|
Drug Volunteers Harder to Find
| |
Strengthened by newer drugs that can make HIV more of a chronic disease, Americans with the virus are much less likely to try unapproved therapies that
could possibly benefit patients worldwide. |
|
|
Sep '03
|
|
Condoms for Elephants?
| |
An alternative logo for next year's World AIDS Conference featuring a male elephant in a sexual position has rankled Thailand's health authorities, who call
it "improper" for Thai culture. |
|
|
Aug '03
|
|
Why Some Poz Stay Healthy
| |
Canadian and US scientists reported last month that people who stay healthy years after HIV infection are more likely than other HIV patients to be infected with virus that has a particular protein alteration. |
|
|
Aug '03
|
|
Spread of HIV Began in 1940, Spurred by War
| |
Strains of HIV largely limited to West Africa appear to have first infected humans in the 1940s, and the current epidemic involving these strains may have originated in 1955-1970 as a result of war, researchers said last month. |
|
|
Aug '03
|
|
Vancouver Cops to Junkies: Die
| |
A police crackdown on drug dealers in Vancouver's downtown Eastside is exacerbating the neighborhood's AIDS and hepatitis epidemic by driving addicts away from needle exchange programs and other services, a Human Rights Watch report says. |
|
|
Aug '03
|
|
New Class of Drugs?
| |
Researchers from the University of Maryland-Baltimore County and Achillion Pharmaceuticals announced the discovery of a new target on the HIV molecule that could lead to a new class of antiviral drugs to fight HIV. |
|
|
|
Prev 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 Next
|
Advertise with us
Subscriptions
Contact us
Site map
Translate
